Indivior Pharmaceuticals (INDV) Gross Margin (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted Gross Margin of 85.71% for Q2 2026, up 2.93 percentage points from 82.78% a year earlier but down 1.67 percentage points from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Gross Margin (2024 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Indivior Pharmaceuticals was 82.06%, up 0.11 percentage points year-over-year; for FY2025, it was 80.23%, down 0.33 percentage points from FY2024.
- Annual Gross Margin shows a four-year change of -3.72 percentage points (FY2021 to FY2025).
- In prior years, Indivior Pharmaceuticals' Gross Margin was 80.56% in FY2024 (-3.52 pp), 84.08% in FY2023 (+0.95 pp), 83.13% in FY2022 (-0.81 pp) and 83.94% in FY2021.
- Quarterly Gross Margin has run from a low of 73.25% in Q3 2025 to a high of 87.38% in Q1 2026 over five years.
- On a year-over-year basis, Gross Margin increased in three of the last six quarters, with an average year-over-year change of +0.93 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 87.38% (Q1 2026), 81.56% (Q4 2025) and 73.25% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Indivior Pharmaceuticals | 4.35 Bn | 3.32 Bn | 294.00 Mn | 85.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.71% |
| Mar 31, 2026 | 87.38% |
| Dec 31, 2025 | 81.56% |
| Sep 30, 2025 | 73.25% |
| Jun 30, 2025 | 82.78% |
| Mar 31, 2025 | 83.08% |
| Dec 31, 2024 | 83.61% |
| Sep 30, 2024 | 78.50% |
| Jun 30, 2024 | 73.58% |
| Mar 31, 2024 | 86.62% |
API Access
Indivior Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();